{"disease":{"id":"pik3ca-mutation-related-tumors","name":"pik3ca mutation related tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06132932","title":"A Study of WX390 in Patients With Advanced Solid Tumors With PIK3CA Mutations","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Shanghai Jiatan Pharmatech Co., Ltd","has_results":false},{"nct_id":"NCT04976439","title":"Patogenic Mutation in 5 Genes","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Dr Cipto Mangunkusumo General Hospital","has_results":false},{"nct_id":"NCT06943313","title":"Breast Cancer PET/CT Imaging With 68Ga-pAKTi","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":20,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05472220","title":"Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Pamela Munster","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}